4/29/2024 2:32:31 AM The FDA’s Continued Search for a Legal Pathway for CBD Products By Elliot Race Elliott is a law clerk at the firm and his work is supervised by licensed attorneys. His admission to the New York bar is pending. During...
4/26/2024 2:28:00 AM HHS Modifies HIPAA Privacy Rule to Shield Reproductive Health Information from Third Party Access By Scot T. Hasselman Lesley Reynolds Nicole Aiken-Shaban Whitney Petrie Taber Rueter Matthew Loughran +3 more... Show less In a final rule published on April 26, the U.S. Department of Health and Human Services (“HHS”) amends the HIPAA Privacy Rule to bolster...
4/23/2024 6:05:16 PM Are you listening, Medicare Advantage and Medicare Part D Plans? It’s CMS (Again) By Scot T. Hasselman Nicole Aiken-Shaban Whitney Petrie Matthew Loughran +1 more... Show less Making good on its promises to enhance oversight of Medicare Advantage (MA) and Medicare Part D plans, the Centers for Medicare and...
4/22/2024 2:50:56 AM FTC, HHS, and DOJ Launch Portal to Report Anticompetitive Health Care Practices By Carol Loepere Michelle Mantine Nicole Aiken-Shaban Courtney Averbach Matthew Loughran +2 more... Show less Last week, on April 18, several federal agencies jointly launched a “one-stop shop” to facilitate reporting of allegedly anticompetitive...
4/16/2024 1:43:25 AM CMS Offers Change Healthcare/Optum Payment Disruption Payments to Medicare Providers and Suppliers By Samantha Beck On March 9, 2024, in response to the cyberattack on UnitedHealth Group’s subsidiary, Change Healthcare/Optum, in late February 2024, the...
4/2/2024 4:13:35 PM FDA Proposed Rule Establishes Criteria for Difficult Drugs to Compound Under Sections 503A and 503B By Kelly Kearney Susan Dewey Amica Nesbitt Madhav Bhatt +1 more... Show less The United States Food and Drug Administration (FDA) has proposed a rule on “Drug Products or Categories of Drug Products that Present...